Skip to main content
FinSpry Logo
FinSpry
XGN logo
XGN
(NASDAQ)
Exagen Inc.
$4.52-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Exagen (XGN) Stock Price & Financial Analysis

Exagen Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.31 - $4.62
52-Week High$12.23
52-Week Low$2.59
Open$4.31
Volume104.16K
Average Volume (3M)582.49K
Market Cap103.89M
Shares Outstanding23.85M
Price to Sales (P/S)1.52
Price to Book (P/B)7.20
EV/EBITDA-8.78
Revenue (TTM)68.38M
Net Income (TTM)-20.17M
Free Cash Flow (TTM)-14.13M
EPS (TTM)$-0.90
Profit Margin-29.49%
Operating Margin-20.65%
Return on Equity (ROE)-139.73%
Debt to Equity1.76
50-Day MA$3.78
200-Day MA$6.04
52-Week Change-37.52%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Exagen

What is the current stock price for XGN?

As of the latest trading session, XGN stock trades at $4.36. The 52-week range is $2.59–$12.23, with a day range of $4.31–$4.62.

What is the P/E ratio for XGN?

The P/E ratio (Price-to-Earnings) for XGN is shown in the Key Statistics section. This valuation metric helps compare Exagen Inc. to industry peers.

Does XGN pay dividends?

Exagen does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XGN?

Based on 5 analysts, the consensus for XGN is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of XGN?

Exagen's market capitalization is $103.9M, classifying it as a micro-cap company. Exagen operates in the Healthcare sector within the Diagnostics & Research industry.